Oncothyreon Inc. (ONTY) Drops 5.44% on January 25

Equities Staff |

Oncothyreon Inc. (ONTY) was one of the Russell 2000's biggest losers for Monday January 25 as the stock slid 5.44% to $1.57, a loss of $-0.09 per share. Starting at an opening price of $1.70 a share, the stock traded between $1.54 and $1.72 over the course of the trading day. Volume was 627,790 shares over 2,582 trades, against an average daily volume of 1.23 million shares and a total float of 94.93 million.

The losses send Oncothyreon Inc. down to a market cap of $148.56 million. In the last year, Oncothyreon Inc. has traded between $4.69 and $1.40, and its 50-day SMA is currently $2.55 and 200-day SMA is $2.92.

Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercialize synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients.

Oncothyreon Inc. is based out of Seattle, WA and has some 49 employees. Its CEO is Christopher S. Henney.

For a complete fundamental analysis analysis of Oncothyreon Inc., check out Equities.com’s Stock Valuation Analysis report for ONTY. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Enertopia Corp

Enertopia Corp is engaged in the exploration of lithium in Nevada, USA. The Company's project includes Central Nevada Lithium Brine Projects.

Private Markets

Dropbox, Inc.

Dropbox is a service that allows their users to bring all photos, docs, and videos anywhere, and share them easily. Any file saved to Dropbox will automatically save to all…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…